ACSBG2 and acute lymphoblastic leukemia: These include the overexpression of LMO1 (overexpressed in T lymphocytes from lymphoblastic leukemia)60, CNPY1 and ACSBG2 in the NK-killing group, which has not been described in NK cells till today.